Beranda › Penyakit Alzheimer › Colorado
Uji klinis Penyakit Alzheimer di Colorado
13 studi untuk Penyakit Alzheimer mencari peserta di lokasi di Colorado.
Kota di Colorado
Teks studi resmi (Bahasa Inggris)
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, Denver
Menerima pesertaFase 2
Usia 55 hingga 90 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06887192A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- CenExel Rocky Mountain Clinical Research, Englewood
Menerima pesertaFase 2
Usia 55 hingga 85 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07589595Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- CenExel Denver, CO, Englewood
Menerima pesertaFase 2
Usia 55 hingga 80 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT06847321A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
- Alpine Clinical Research Center - Boulder - 47th Street /ID# 277856, Boulder
Menerima pesertaFase 1/2
Usia 50 hingga 90 · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT07599670A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- Research of the Rockies, Colorado Springs
Menerima pesertaFase 3
Usia 60 hingga 85 · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT06976203Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- University of Colorado Anschutz Medical Campus, Aurora
Menerima pesertaFase 2
Usia 55 hingga 90 · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT06808984A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Mountain Neurological Research Center, Basalt
Menerima pesertaFase 3
Usia 60 hingga 85 · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT06976216Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- University of Colorado Anschutz, Aurora
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 4 Agu 2026 · NCT06563895CBD for Individuals at Risk for Alzheimer's Disease
- University of Colorado - Anschutz Medical Campus, Aurora
Menerima pesertaFase 2
Usia 55 hingga 85 · Semua jenis kelamin · Diperbarui 15 Jun 2026 · NCT05822362Trial-Ready Cohort-Down Syndrome (TRC-DS)
- Linda Crnic Institute for Down Syndrome, University of Colorado, Aurora
Menerima pesertaStudi observasional
Usia 25 hingga 55 · Semua jenis kelamin · Diperbarui 18 Mei 2026 · NCT04165109Phase II Trial to Evaluate Safety and Efficacy of GM-CSF/Sargramostim in Alzheimer's Disease
- University of Colorado Anschutz Medical Campus, Aurora
Menerima pesertaFase 2
Usia 60 hingga 85 · Semua jenis kelamin · Diperbarui 30 Apr 2026 · NCT04902703Intervention to Collect and Utilize Sexual Orientation and Gender Identity (SOGI) Information in Hospice
- University of Colorado, Aurora
Menerima pesertaSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Jun 2024 · NCT05877391Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
- Vivage/Beecan Corporation, Lakewood
Menerima peserta
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 12 Mar 2024 · NCT05820919Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.